Maryann Gold, NP
Nurse Practitioner · Dickinson, NDNPI 1891825733
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 279 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 37 manufacturers, the largest accounting for just 16.0% — the pattern of someone who eats at a lot of different presentations. Among nurse practitioner clinicians in ND with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 279 payments — averaging $14.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$656
- AbbVie$395
- Lundbeck LLC$311
- Lilly USA, LLC$254
- Novartis$223
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$194
- plus $2K from 31 others
What the payments were for
- Food & beverage$4,107100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 52 | $656 |
| AbbVie | 36 | $395 |
| Lundbeck LLC | 19 | $311 |
| Lilly USA, LLC | 23 | $254 |
| Novartis | 13 | $223 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 9 | $194 |
| GSK | 19 | $189 |
| AstraZeneca | 5 | $176 |
| Pfizer | 13 | $176 |
| Astellas Pharma US Inc | 9 | $171 |
| Novo Nordisk | 11 | $166 |
| E.r. Squibb & Sons, L.L.C. | 9 | $136 |
| Medtronic | 1 | $109 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $89 |
| Merck | 6 | $89 |
| Supernus Pharmaceuticals, Inc. | 5 | $84 |
| Bayer | 5 | $74 |
| Biohaven Pharmaceutical Holding Company Ltd. | 5 | $68 |
| Dexcom, Inc. | 4 | $66 |
| Boehringer Ingelheim | 4 | $61 |
| Verona Pharma, Inc. | 3 | $55 |
| Abbott | 3 | $49 |
| Exact Sciences | 3 | $48 |
| Axsome Therapeutics, Inc. | 2 | $38 |
| Actelion Pharmaceuticals US, Inc. | 2 | $36 |
| Edwards Lifesciences | 1 | $33 |
| Johnson & Johnson | 1 | $20 |
| Sanofi-aventis U.S. LLC | 1 | $17 |
| Neurocrine Biosciences, Inc. | 1 | $17 |
| Mylan Specialty L.p. | 1 | $17 |
| Acadia Pharmaceuticals Inc | 1 | $15 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $15 |
| Ultragenyx Pharmaceutical Inc. | 1 | $14 |
| Lexicon Pharmaceuticals, Inc. | 1 | $14 |
| Alkermes, Inc. | 1 | $13 |
| Athena Bioscience, LLC | 1 | $12 |
| Corium, LLC | 1 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AIRSUPRA$119
- FARXIGA$119
- BREZTRI$119
- MINIMED 780G$109
How this compares
$4,107 in reported general payments places this provider in the 95th percentile of 455 nurse practitioner providers in North Dakota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EnbrelEtanercept | 13 | $98,542 |
| JardianceEmpagliflozin | 102 | $68,728 |
| EliquisApixaban | 89 | $51,569 |
| OzempicSemaglutide | 32 | $45,715 |
| MounjaroTirzepatide | 28 | $30,984 |
| XareltoRivaroxaban | 28 | $21,088 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 13 | $20,725 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 27 | $17,152 |
| TrulicityDulaglutide | 17 | $17,024 |
| Tresiba Flextouch U-100Insulin Degludec | 23 | $14,332 |
| DuleraMometasone/Formoterol | 30 | $10,375 |
| MyrbetriqMirabegron | 23 | $8,874 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 16 | $8,375 |
| Breo ElliptaFluticasone/Vilanterol | 18 | $7,400 |
| Xtampza ErOxycodone Myristate | 12 | $7,056 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AmgenEnbrel | $656 | $98,54213 claims |
| Boehringer IngelheimJardiance | $61 | $68,728102 claims |
| PfizerEliquis | $176 | $51,56989 claims |
| Lilly USA, LLCMounjaro, Trulicity | $254 | $48,00845 claims |
| Novo NordiskOzempic | $166 | $45,71532 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Incruse Ellipta | $189 | $35,14750 claims |
| Johnson & JohnsonXarelto | $20 | $21,08828 claims |
| AstraZenecaBreztri Aerosphere | $176 | $17,15227 claims |
| MerckDulera, Januvia | $89 | $16,27541 claims |
| Astellas Pharma US IncMyrbetriq | $171 | $8,87423 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Vyvanse | $89 | $5,61115 claims |
| AbbVieSynthroid | $395 | $2,03325 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 455 nurse practitioner providers in North Dakota.
Other nurse practitioner in Dickinson
- Brianna OlsonDickinson$2K
- Emily GreensteinFargo$271K
- Sarah MatchaFargo$17K
- Jana SuderFargo$16K
- Lisa ClairmontBismarck$15K
- Jenna KelschMinot$9K
- McKinzie NussBismarck$7K
- Nicole MorganGrand Forks$7K
- Paula MochBismarck$5K
- Trina KaiserBismarck$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.